Pharmaceutical Business review

Berkshire Hathaway acquires Lubrizol

Lubrizol is a producer of ingredients and additives for personal care products and pharmaceuticals; specialty materials, as well as plastics technology and performance coatings in the form of specialty resins and additives.

With this acquisition, Lubrizol has now become a wholly-owned subsidiary of Berkshire Hathaway.

Lubrizol chairman, president and CEO James Hambrick said as part of Berkshire Hathaway, they have significant opportunities to continue creating customer value by providing chemistries, formulations and solutions for some of the most demanding performance applications in the world.